128 related articles for article (PubMed ID: 36251366)
1. Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators.
Del Giudice F; D'Andrea D; Pradere B; Berndl F; Pallauf M; Flammia RS; Philipp D; Moschini M; Mari A; Albisinni S; Krajewski W; Laukhtina E; Gallioli A; Mertens LS; Marcq G; Cimadamore A; Afferi L; Gontero P; Shariat SF; Chung BI; Soria F
BJU Int; 2023 Jun; 131(6):712-719. PubMed ID: 36251366
[TBL] [Abstract][Full Text] [Related]
2. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
[TBL] [Abstract][Full Text] [Related]
4. Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour.
Suarez-Ibarrola R; Soria F; Abufaraj M; D'Andrea D; Preto M; Gust KM; Briganti A; Shariat SF; Gontero P
BJU Int; 2019 Apr; 123(4):646-650. PubMed ID: 30248235
[TBL] [Abstract][Full Text] [Related]
5. Quality Control Indicators for Transurethral Resection of Bladder Tumor: Results from an Embedded Belgian Multicenter Prospective Registry.
Muilwijk T; Akand M; Raskin Y; Jorissen C; Vander Eeckt K; Van Bruwaene S; Van Cleynenbreugel B; Joniau S; Van Der Aa F
Eur Urol Oncol; 2023 Aug; 6(4):422-430. PubMed ID: 36543720
[TBL] [Abstract][Full Text] [Related]
6. Improving the quality of operative reports for transurethral resection of bladder tumor surgery in resident education.
Haddad J; Anderson C; Heinlen J; Stratton K; Mellis A; Herr H; Cookson M; Patel S
Can J Urol; 2017 Oct; 24(5):8976-8981. PubMed ID: 28971783
[TBL] [Abstract][Full Text] [Related]
7. Quality improvement in managing patients with non-muscle-invasive bladder cancer by introducing a surgical checklist for transurethral resection of bladder tumor.
Kikuchi H; Osawa T; Abe T; Matsumoto R; Maruyama S; Murai S; Shinohara N
PLoS One; 2022; 17(10):e0276816. PubMed ID: 36301957
[TBL] [Abstract][Full Text] [Related]
8. Surgical experience is predictive for bladder tumour resection quality.
Bube SH; Brix R; Christensen MB; Thostrup M; Grimstrup S; Hansen RB; Dahl C; Konge L; Azawi N
Scand J Urol; 2022; 56(5-6):391-396. PubMed ID: 36065477
[TBL] [Abstract][Full Text] [Related]
9. Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial.
Gakis G; Karl A; Bertz S; Burger M; Fritsche HM; Hartmann A; Jokisch F; Kempkensteffen C; Miller K; Mundhenk J; Schneevoigt BS; Schubert T; Schwentner C; Wullich B; Stenzl A
BJU Int; 2020 Oct; 126(4):509-519. PubMed ID: 32578332
[TBL] [Abstract][Full Text] [Related]
10. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
[TBL] [Abstract][Full Text] [Related]
11. Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic response.
Hensley PJ; Bree KK; Brooks N; Matulay J; Li R; Nogueras González GM; Navai N; Grossman HB; Dinney CP; Kamat AM
BJU Int; 2021 Nov; 128(5):634-641. PubMed ID: 33783950
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis.
Krajewski W; Nowak Ł; Poletajew S; Tukiendorf A; Moschini M; Mari A; Di Trapani E; Xylinas E; Kiełb P; Wełna M; Zdrojowy R
J Endourol; 2020 Aug; 34(8):795-804. PubMed ID: 32336149
[No Abstract] [Full Text] [Related]
13. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
14. Perioperative outcomes of transurethral resection for t1 bladder tumors: quality evaluation based on patient, tumor and surgeon criteria.
Bebane S; Denize J; Goujon A; Meria P; Verine J; Mongiat-Artus P; Desgrandchamps F; Masson-Lecomte A
World J Urol; 2021 Nov; 39(11):4159-4165. PubMed ID: 34160681
[TBL] [Abstract][Full Text] [Related]
15. Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes.
Graffeille V; Verhoest G; Gryn A; Kammerer-Jacquet SF; Alimi Q; Beauval JB; Beuzit L; Pradère B; Thoulouzan M; Khene ZE; Guille F; Rioux-Leclercq N; Mathieu R; Gamé X; Bensalah K; Soulié M; Roumiguié M; Peyronnet B
Urol Int; 2022; 106(2):122-129. PubMed ID: 33626547
[TBL] [Abstract][Full Text] [Related]
16. Blue vs white light for transurethral resection of non-muscle-invasive bladder cancer: an abridged Cochrane Review.
Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P
BJU Int; 2022 Dec; 130(6):730-740. PubMed ID: 35238145
[TBL] [Abstract][Full Text] [Related]
17. Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Pak JS; Haas CR; Anderson CB; DeCastro GJ; Benson MC; McKiernan JM
Urol Oncol; 2021 Nov; 39(11):787.e9-787.e15. PubMed ID: 33865688
[TBL] [Abstract][Full Text] [Related]
18. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
[TBL] [Abstract][Full Text] [Related]
19. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
Mastroianni R; Brassetti A; Krajewski W; Zdrojowy R; Salhi YA; Anceschi U; Bove AM; Carbone A; De Nunzio C; Fuschi A; Ferriero M; Nacchia A; Pastore AL; Tema G; Tuderti G; Gallucci M; Simone G
Eur Urol Focus; 2021 Nov; 7(6):1324-1331. PubMed ID: 32900676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
